Alastair Hick

Alastair Hick is a highly experienced professional in research and technology commercialization, currently serving as a Director at BioCurate Pty Ltd.34 His extensive career spans over 20 years in the field, with a strong focus on translating academic research into commercial applications.

Professional Background

Current Roles

• Chief Commercialisation Officer at Monash University (since April 2022)2
• Director at BioCurate Pty Ltd3
• Director at Jupiter Ionics and PIOtx2

Previous Positions

• Senior Director and Director of Monash Innovation at Monash University (2007-2022)2
• Chair of Knowledge Commercialisation Australasia (2015-2018)2
• Director at Amaero International Limited (2013-2019)2
• Head of Life Sciences at Cambridge Enterprise (2002-2006)2

Education and Qualifications

Alastair Hick holds several advanced degrees and professional qualifications:

• PhD in Chemical Ecology1
• MBA from the Judge Business School, University of Cambridge2
• BSc (Hons) in Chemistry with Biochemistry from the University of Southampton2
• Graduate of the Australian Institute of Company Directors (GAICD)2

Expertise and Contributions

Dr. Hick is recognized for his expertise in:

• Research and technology commercialization
• Developing successful licensing and spin-out programs
• Managing proof of concept funds and strategic partnerships with investors
• Overseeing entrepreneurship programs in academic settings

His contributions to the field have been acknowledged through his inclusion in the IAM Strategy 300: The World's Leading IP Strategists in 2020 and 2021.2

Professional Affiliations

Alastair Hick has been involved with several professional organizations:

• Member of the National Health and Medical Research Council's Health Research Impact Committee2
• Former member of the IP Australia Stakeholders Forum1
• Investment Committee Member for the Trans Tasman Commercialisation Fund2

Through his various roles and extensive experience, Alastair Hick has made significant contributions to bridging the gap between academic research and commercial applications in Australia and internationally.